Seasonal Influenza mRNA Vaccine Clinical Trials
Each flu season brings added risk for older adults, and research is helping shape the next generation of influenza vaccines. 3A Research conducted a Seasonal Influenza mRNA Vaccine Clinical Trial in adults aged 65 and older. This study is no longer recruiting.
This study is no longer recruiting.
The information below is kept for reference only.
Seasonal Influenza mRNA Vaccine Clinical Trials
Understanding the Condition
Influenza (the flu) is a contagious respiratory illness caused by influenza viruses. It can cause fever, cough, sore throat, body aches, and fatigue, and symptoms range from mild to severe.
Adults aged 65 and older are at higher risk of serious flu-related complications. Seasonal vaccination is a key tool used to help reduce this risk, and researchers continue to study new vaccine approaches.
By taking part in a Seasonal Influenza Vaccine Research Study in Texas, older adults helped researchers understand how investigational vaccines may perform in this age group.
Important Information About Participation
Participation in Seasonal Influenza mRNA Vaccine Clinical Trials is voluntary. Investigational vaccines are studied for safety and effectiveness, but there is no guarantee of personal benefit. Studies are conducted under strict regulatory guidelines. Consult with your healthcare provider before enrolling in any clinical research study.
- Age
- 65 Years and older
- Gender
- Males and Females
- Condition
- Seasonal Influenza
- Location
- Texas
About the Seasonal Influenza mRNA Vaccine Study
This Phase 3 study is evaluating an investigational mRNA-based seasonal influenza vaccine in adults aged 65 and older. Researchers are gathering information about how well the investigational vaccine works in this age group. It is not yet known whether it is safe or effective for this use.
This study is no longer recruiting. The information here is provided for reference and to give an overview of the research that was conducted.
What to Expect in Seasonal Influenza Vaccine Clinical Trials
Clinical trials give participants access to study-related care and monitoring under expert medical supervision. Participants underwent health evaluations, received the study vaccine, and attended follow-up visits. This study is no longer recruiting. You can view the studies we are currently recruiting for to find one that may be right for you.
Frequently Asked Questions
This study focused on adults aged 65 and older who met the study's eligibility criteria.
No. This study is no longer recruiting. You can view the studies we are currently recruiting for to see if another study may be a fit.
Adults aged 65 and older are at higher risk of serious flu-related complications, so research often focuses on how vaccines can help protect this age group.
An mRNA vaccine gives the body instructions to make a harmless piece of protein that helps the immune system recognize and respond to a virus. The vaccine in this study is investigational, meaning it is still being evaluated.
You can view the studies we are currently recruiting for at any time, or contact our team to learn more about taking part in current research.